OBJECTIVE: There is cross-sectional evidence that neurocognitive intra-individual variability (IIV), or dispersion, is elevated in human immunodeficiency virus (HIV) disease and is associated with declines in activities of daily living, including medication adherence. METHODS: This longitudinal study extends this literature by examining whether increased neurocognitive IIV in HIV-positive persons over time predicts declines in medication adherence above and beyond changes in mean level of performance over a 6-month observation. RESULTS: After controlling for drug use, declines in mean performance, and changes in depressive symptoms, results confirmed that increases in IIV were associated with overall poorer antiretroviral medication adherence. HIV-positive individuals with the greatest increases in dispersion demonstrated marked reductions in adherence by the third month that exceeded what was observed in less variable individuals. CONCLUSIONS: Our results indicate that increases in dispersion are associated with poorer declines in medication adherence in HIV disease, which may have implications for the early detection and remediation of suboptimal antiretroviral adherence. (c) 2015 APA, all rights reserved).
OBJECTIVE: There is cross-sectional evidence that neurocognitive intra-individual variability (IIV), or dispersion, is elevated in human immunodeficiency virus (HIV) disease and is associated with declines in activities of daily living, including medication adherence. METHODS: This longitudinal study extends this literature by examining whether increased neurocognitive IIV in HIV-positive persons over time predicts declines in medication adherence above and beyond changes in mean level of performance over a 6-month observation. RESULTS: After controlling for drug use, declines in mean performance, and changes in depressive symptoms, results confirmed that increases in IIV were associated with overall poorer antiretroviral medication adherence. HIV-positive individuals with the greatest increases in dispersion demonstrated marked reductions in adherence by the third month that exceeded what was observed in less variable individuals. CONCLUSIONS: Our results indicate that increases in dispersion are associated with poorer declines in medication adherence in HIV disease, which may have implications for the early detection and remediation of suboptimal antiretroviral adherence. (c) 2015 APA, all rights reserved).
Authors: Mark L Ettenhofer; Jessica Foley; Nina Behdin; Andrew J Levine; Steven A Castellon; Charles H Hinkin Journal: Arch Clin Neuropsychol Date: 2010-08-26 Impact factor: 2.813
Authors: Andrew J Levine; David J Hardy; Terry R Barclay; Matthew J Reinhard; Michael M Cole; Charles H Hinkin Journal: J Clin Exp Neuropsychol Date: 2007-03-12 Impact factor: 2.475
Authors: R K Heaton; D B Clifford; D R Franklin; S P Woods; C Ake; F Vaida; R J Ellis; S L Letendre; T D Marcotte; J H Atkinson; M Rivera-Mindt; O R Vigil; M J Taylor; A C Collier; C M Marra; B B Gelman; J C McArthur; S Morgello; D M Simpson; J A McCutchan; I Abramson; A Gamst; C Fennema-Notestine; T L Jernigan; J Wong; I Grant Journal: Neurology Date: 2010-12-07 Impact factor: 9.910
Authors: James T Becker; Mary Amanda Dew; Howard J Aizenstein; Oscar L Lopez; Lisa Morrow; Judith Saxton; Lluís Tárraga Journal: Disabil Rehabil Date: 2012-03-30 Impact factor: 3.033
Authors: David E Vance; Pariya L Fazeli; Lesley A Ross; Virginia G Wadley; Karlene K Ball Journal: J Assoc Nurses AIDS Care Date: 2012-05-11 Impact factor: 1.354
Authors: Ariana E Anderson; Jacob D Jones; Nicholas S Thaler; Taylor P Kuhn; Elyse J Singer; Charles H Hinkin Journal: Neuropsychology Date: 2018-09-13 Impact factor: 3.295
Authors: Joseph D Harrison; Jessica A Dochney; Sonja Blazekovic; Frank Leone; David Metzger; Ian Frank; Robert Gross; Anita Hole; Karam Mounzer; Steven Siegel; Robert A Schnoll; Rebecca L Ashare Journal: J Neurovirol Date: 2017-04-20 Impact factor: 2.643
Authors: Lindsay J Hines; Eric N Miller; Charles H Hinkin; Jeffery R Alger; Peter Barker; Karl Goodkin; Eileen M Martin; Victoria Maruca; Ann Ragin; Ned Sacktor; Joanne Sanders; Ola Selnes; James T Becker Journal: Brain Imaging Behav Date: 2016-09 Impact factor: 3.978
Authors: Drenna Waldrop; Crista Irwin; W Chance Nicholson; Cheryl A Lee; Allison Webel; Pariya L Fazeli; David E Vance Journal: J Assoc Nurses AIDS Care Date: 2021 May-Jun 01 Impact factor: 1.809
Authors: Jacob D Jones; Taylor Kuhn; Zanjbeel Mahmood; Elyse J Singer; Charles H Hinkin; April D Thames Journal: Neuropsychology Date: 2017-09-11 Impact factor: 3.424